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Abstract
OBJECTIVE: To explore the characteristics of prima-
ry liver cancer in terms of Traditional Chinese Medi-
cine (TCM) by analyzing the variations of the pat-
terns along with the clinical stages.
METHODS: The patients who were hospitalized in
the Changhai Hospital of Traditional Chinese Medi-
cine dated from March 1999 to December 2008
were included in this retrospective study. The pa-
tients were grouped according to their cancer stag-
es, and their patterns were judged and quantified
according to the "Standard diagnosis and quantita-
tive criteria of the common patterns in primary liv-
er cancer" formulated by the Changhai Hospital of
Traditional Chinese Medicine. Statistics methods in-
cluded ANOVA and nonparametric test, among
others.
RESULTS: The data of the 398 newly diagnosed pa-
tients showed that Qi Stagnation, Blood Stasis, and
Dampness patterns were more frequent than the
other basic patterns with relatively high scores; pat-
terns of Liver Qi Stagnation, Liver Blood Stasis, and
Dampness Heat were more than the other complex
patterns and scored relatively high. Scores of
Dampness and Liver Qi Stagnation patterns varied
among the groups at different stages and the differ-
ences were statistically significant (PDampness = 0.002,
PLiver Qi Stagnation = 0.020). The highest scores of Damp-
ness pattern and Liver Qi Stagnation pattern corre-
sponded with StageⅢb, and StageⅢa, respective-
ly. Dampness pattern frequency was higher (P =
0.001) in the StageⅢb group than in other groups.
CONCLUSION: Pattern characteristics in patients
with primary liver cancer of different clinical stages
might manifest in the variations of the Dampness
pattern along the process of the disease and the
major pathogenic factor of primary liver cancer
might be Dampness.
© 2015 JTCM. All rights reserved.
Key words: Carcinoma, hepatocellular; Neoplasm
staging; Medicine, Chinese traditional; Pattern
INTRODUCTION
Primary liver cancer (PLC) is the fifth most common
cancer worldwide and its mortality ranks third among
all other major cancers.1 More than half of the new an-
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nual cases (749 000) and 695 000 deaths attributed to
PLC worldwide occur in China.2 Unfortunately,
PLC-related incidence and mortality continue to rise
according to data from the Chinese cancer registry sys-
tem.3 PLC is considered as a disease with a complex
pathogenesis and poor prognosis; it is estimated that
the 5-year survival rate is less than 30% even for local-
ized liver cancer, and the average 5-year survival rate
for all stages is approximately 15%.4 The poor progno-
sis is mainly attributed to the high recurrence rate after
curative hepatectomy and the lack of effective adjuvant
therapy.5 However, Traditional Chinese Medicine
(TCM) has contributed considerably to the prevention
and treatment of PLC by prolonging survival time,
postponing tumor recurrence and metastasis, and im-
proving quality of life and alleviation of symptoms.6-8
Moreover, it has been reported that the specific TCM
patterns or TCM constitution could be independent
factors for survival of patients with PLC.9,10
Pattern differentiation combined with the characteris-
tics of the disease itself is a distinguishing feature of
TCM treatment; thus, patterns are the premise of
TCM therapy. Therefore, the differentiation of pat-
terns is the key step, and the TCM pathogenesis, based
on the characteristics of the disease itself, is the quicker
and easier path to obtaining satisfying therapeutic out-
comes. However, there is no widely accepted standard
for the pattern differentiation of PLC yet, and the posi-
tions regarding the pathogenesis seem to vary. TCM
pattern characteristics through the process of oncogene-
sis and PLC development help to deduce the TCM
pathogenesis. In this study, we analyzed the pattern of
398 patients newly diagnosed with PLC and compared
the pattern characteristics among the different stage
groups to supply more data that can be used to summa-
rize the TCM pathogenesis of PLC.
MATERIALS ANDMETHODS
Subjects and diagnosis standard
In total, 398 newly diagnosed patients, who were hos-
pitalized in the Changhai Hospital of Traditional Chi-
nese Medicine from March 1999 to December 2008
and were diagnosed with the "Clinical diagnosis and
staging standard of PLC," presented during the 8th Na-
tional Liver Cancer Academic Conference in Guang-
zhou, September 2001.11
Classification of the patterns
The patterns of PLC were classified into eight basic pat-
terns and seven complex patterns referring to the "Stan-
dard diagnosis and quantitative criteria of the common
patterns on PLC" 12,13 formulated by the Changhai Hos-
pital of Traditional Chinese Medicine.
Basic patterns: Qi Stagnation, Blood Stasis, Excessive
Heat, Dampness, Qi Deficiency, Blood Deficiency, Yin
Deficiency, and Yang Deficiency.
Complex patterns: Liver Qi Stagnation, Liver Blood
Stasis, Dampness Heat, Spleen Qi Deficiency, Liver
and Kidney Yin Deficiency, Liver Blood Deficiency,
and Spleen and Kidney Yang Deficiency.
Diagnosis was made according to the qualitative diag-
nostic criteria, and the patterns were scored with quan-
titative criteria. The basic pattern qualitative diagnostic
criteria and quantitative criteria have been published
previously.12,13 The complex pattern qualitative diagnos-
tic criteria and quantitative criteria are listed as follows:
Diagnostic criteria of TCM complex patterns
Liver Qi Stagnation: major symptoms and signs: un-
fixed or distending pain in the hypochondriac region,
epigastric distension; minor symptoms and signs: de-
pression, frequent sighs, chest stuffiness, stringy pulse.
Liver blood stasis: major symptoms and signs: sublin-
gual varices, purple tongue, petechiae or bruise in the
tongue; minor symptoms and signs: mass in hypochon-
driac region, pricking, liver palms, spider angioma.
Dampness Heat: major symptoms and signs: Yellowish
fur or greasy fur; minor symptoms and signs: dark
urine, jaundice, bitter mouth, deep red tongue, dry
throat.
Spleen Qi Deficiency: major symptoms and signs: an-
orexia, loose stool, mental fatigue; minor symptoms
and signs: physical fatigue, tasteless, scallop tongue,
swollen tongue, weak pulse.
Liver and Spleen Yin Deficiency: major symptoms and
signs: soreness and weakness of waist and knees, dark
red tongue, stripped fur or smooth tongue; minor
symptoms and signs: tidal fever, night sweat, feverish
sensation in chest palms and soles, thready pulse
Liver Blood Deficiency: major symptoms and signs:
vertigo, insomnia, light white tongue; minor symp-
toms and signs: palpitation, sallow or pale complexion
Spleen and Kidney Yang Deficiency: major symptoms
and signs: aversion to cold, soreness and weakness of
waist and knees, light white tongue; minor symptoms
and signs: frequent urination, clear abundant urine,
nocturia, dawn diarrhea, diarrhea with undigested food.
A patient with two items of major symptoms and signs
plus one item of the minor symptoms and signs of a
certain pattern can be considered to have that pattern.
A patient with one item of major symptoms and signs
plus two items of minor symptoms and signs of a cer-
tain pattern also can be judged to have that pattern.
Scoring system of the complex patterns
Liver Qi Stagnation: depression (X1), frequent sigh
(X2), chest stuffiness (X3), epigastric distension (X4), un-
fixed or distending pain in the hypochondriac region
(X5), stringy pulse (X6)
GI Liver Qi Stagnation＝0.2854 X1＋0.2854 X2＋0.1260 X3＋0.1260
X4＋0.1260 X5＋0.0511 X6
Liver Blood Stasis: sublingual varices (X1), purple
tongue (X2), lump in hypochondriac region (X3), spi-
der angioma (X4), liver palms (X5), petechiae or bruise
in the tongue (X6), pricking (X7)
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GI Liver Blood Stasis＝0.2357 X1＋ 0.2357 X2＋ 0.2357 X3＋ 0.0854
X4＋0.0854 X5＋0.0854 X6＋0.0366 X7
Dampness Heat: jaundice (X1), dark urine (X2), bitter
mouth (X3), dry throat (X4), yellowish fur (X5), greasy
fur (X6), deep red tongue (X7)
GI Dampness Heat＝0.2909 X1＋0.2909 X2＋0.1184 X3＋0.1184 X4＋
0.0693 X5＋0.0693 X6＋0.043X7
Spleen Qi Deficiency: anorexia (X1), tasteless (X2), fa-
tigue (X3), scallop tongue (X4), swollen tongue (X5),
weak pulse (X6)
GI Spleen Qi Deficiency＝0.2585 X1＋0.2585 X2＋0.2585 X3＋0.0979
X4＋0.0979 X5＋0.0286 X6
Liver and Spleen Yin Deficiency: tidal fever (X1), night
sweat (X2), soreness and weakness of waist and knees
(X3), feverish sensation in chest, palms and soles (X4),
dark red tongue (X5), stripped fur or smooth tongue
(X6), thready pulse (X7)
GI Liver and Spleen Yin Deficiency＝0.2986 X1＋ 0.2986 X2＋ 0.1313 X3＋
0.1313 X4＋0.0563 X5＋0.0563 X6＋0.0276 X7
Liver Blood Deficiency: vertigo (X1), palpitation (X2),
insomnia (X3), light white tongue (X4), sallow or pale
complexion (X5)
GI Liver Blood Deficiency＝0.2667 X1＋0.2667 X2＋0.2667 X3＋0.1333
X4＋0.0667 X5
Spleen and Kidney Yang Deficiency: frequent urination
(X1), nocturia (X2), clear and abundant urine (X3), Aver-
sion to cold (X4) diarrhea with undigested food (X5),
dawn diarrhea (X6)
GI Spleen and Kidney Yang Deficiency＝0.2475 X1＋0.2475 X2＋0.2475 X3＋
0.1417 X4＋0.0578 X5＋0.0578 X6
Procedure of the study
All the data were retrieved, by Meng Jing (Department
of Oncology, Chinese People's Liberation Army Gener-
al Hospital) from the PLC Clinical Data System estab-
lished by the Changhai Hospital of Traditional Chinese
Medicine. Search terms included "hospitalized from
March 1999 to December 2008", "newly diagnosed",
and "primary liver cancer", and the integral data of
398 patients were obtained.
Data on staging, pattern differentiation, and basic in-
formation were managed with Epidata 3.1 (The EpiDa-
ta Association, Odense, Denmark) after double entry
and checks.
The pattern diagnoses were determined based on the
data, in the form of a questionnaire, collected from the
patients when they were enrolled. The questionnaires
included comprehensive TCM signs and symptoms. If
the answer to a certain sign was "yes", then one point
was awarded to that item, and if the answer was "no",
no point was awarded. All the symptoms were classi-
fied as mild, moderate, and severe; mild symptoms
were awarded one point, moderate symptoms were
awarded two points, and severe ones were awarded
three points. If the patient was asymptomatic, no
points were awarded. The questionnaire included a few
descriptive suggestions to help the patients judge how
to classify their symptoms. The TCM pattern question-
naires were completed under the guidance of the physi-
cian in charge.
Patterns were diagnosed and quantified using the "Stan-
Item
Demographic
Chronic liver disease
Child-Pugh Classification
Clinical stage
ECOG score
Characteristic
Gender [Male (%), Female (%)]
Age (years, xˉ ± s)
HBV [Yes (%)/No (%)]
Cirrhosis [Yes (%)/No (%)]
A [n (%)]
B [n (%)]
C [n (%)]
Ⅱa [n (%)]
Ⅱb [n (%)]
Ⅱa [n (%)]
Ⅱb [n (%)]
Ⅲa [n (%)]
Ⅲb [n (%)]
0 [n (%)]
1 [n (%)]
2 [n (%)]
3 [n (%)]
4 [n (%)]
Data (n = 398)
351 (88.2)/47 (11.8)
54±11
356 (89.4)/42 (10.6)
325 (81.7)/73 (18.3)
285 (71.6)）
90 (22.6)
23 (5.8)
26 (6.5)
26 (6.5)
53 (13.3)
110 (27.6)
155 (38.9)
28 (7.0)
4 (1.0)
61 (15.3)
237 (59.5)
69 (17.3)
27 (6.8)
Notes: SD: standard deviation; HBV: hepatitis B virus; ECOG: eastern cooperative oncology group.
Table 1 Baseline characteristics of 398 patients with primary liver cancer
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dard diagnosis and quantitative criteria of the common
patterns on PLC". Severities of the patterns were quan-
tized by scores, and their incidences were determined
by frequency distribution.
Finally, the pattern characteristics of the PLC patients
in different staging groups were explored by comparing
their pattern incidence and the scores of each pattern.
Statistical analysis software SPSS 16.0 (SPSS Inc., Chi-
cago, IL, USA) was applied and the statistical signifi-
cance was set at P < 0.05. Scores of patterns in differ-
ent stage groups were analyzed by nonparametric test
(Kruskal-Wallis). Regarding the multiple comparisons
of the score, analysis of variance test was applied after
the rank transformation. Frequencies of the patterns
were analyzed using the Chi-square test.
RESULTS
Baseline information
There were 398 patients eligible for the study, with an
average age of (54 ± 11) years. Among them, 26
Pattern
B1
B2
B3
B4
B5
B6
B7
B8
C1
C2
C3
C4
C5
C6
C7
Pattern scores [ xˉ ± s (median)]
StageⅠa
(n = 26)
5.84±5.84
(4.27)
10.40±9.35
(8.24)
3.00±2.30
(3.21)
10.04±8.38
(7.71)
4.73±7.01
(0.00)
5.39±6.40
(3.83)
1.63±3.92
(0.00)
2.18±5.08
(0.00)
6.67±8.56
(5.11)
11.72±11.02
(7.86)
11.37±11.68
(8.36)
4.52±6.30
(0.00)
3.92±5.15
(2.76)
4.66±7.23
(0.00)
1.57±5.05
(0.00)
StageⅠb
(n = 26)
7.22±8.73
(4.27)
7.05±8.26
(5.49)
3.50±5.07
(2.37)
11.67±7.95
(13.17)
3.85±6.42
(0.00)
3.93±6.00
(3.83)
1.81±5.82
(0.00)
3.62±6.75
(0.00)
6.45±7.55
(5.11)
10.26±9.15
(8.54)
9.96±8.01
(8.36)
4.37±5.46
(0.00)
3.31±6.97
(1.88)
3.62±5.53
(0.00)
0.96±3.34
(0.00)
StageⅡa
(n = 53)
8.48±9.26
(4.27)
11.85±11.10
(8.42)
2.82±2.97
(2.54)
8.49±6.81
(7.71)
5.05±6.05
(3.18)
5.60±7.23
(3.83)
1.23±2.90
(0.00)
3.77±8.57
(0.00)
6.99±8.78
(5.11)
11.89±10.73
(7.86)
10.19±8.48
(8.36)
4.98±5.40
(3.69)
2.91±4.40
(1.88)
6.07±8.04
(0.00)
2.37±9.10
(0.00)
StageⅡb
(n = 110)
9.94±11.55
(4.27)
11.23±11.67
(6.97)
5.42±8.30
(3.21)
10.50±9.66
(7.71)
6.06±9.30
(0.00)
6.91±8.43
(3.83)
3.83±7.76
(0.00)
3.57±8.99
(0.00)
8.90±9.06
(5.11)
12.86±11.14
(7.86)
14.35±14.29
(9.24)
5.38±7.53
(0.00)
5.51±8.33
(2.76)
7.18±12.29
(0.00)
3.17±8.67
(0.00)
StageⅢa
(n = 155)
9.26±10.06
(4.27)
12.76±11.99
(9.47)
4.68±6.27
(3.21)
11.21±11.02
(7.71)
6.20±8.64
(3.24)
5.30±6.93
(3.83)
2.33±5.47
(0.00)
2.83±6.86
(0.00)
8.85±8.11
(5.11)a
12.85±10.63
(8.54)
13.08±13.77
(9.24)
5.22±7.49
(0.00)
4.08±7.03
(1.88)
5.04±8.76
(0.00)
2.96±8.04
(0.00)
StageⅢb
(n = 28)
11.71±17.22
(4.27)
14.79±13.08
(9.00)
3.75±3.62
(3.21)
21.49±15.38
(20.47)b
6.95±13.61
(3.18)
7.49±10.67
(3.83)
1.24±2.57
(0.00)
0.00±0.00
(0.00)
7.90±14.18
(5.11)
16.83±9.86
(16.40)
15.68±16.73
(10.90)
5.48±7.98
(1.85)
1.86±2.05
(1.88)
4.25±7.53
(0.00)
0.69±1.83
(0.00)
P value
0.544
0.106
0.234
0.002
0.554
0.769
0.229
0.232
0.020
0.159
0.540
0.976
0.090
0.796
0.629
Notes: B1: Qi Stagnation; B2: Blood Stasis; B3: Excessive Heat; B4: Dampness; B5: Qi Deficiency; B6: Blood Deficiency; B7: Yin Defi-
ciency; B8: Yang Deficiency; C1: Liver Qi Stagnation; C2: Liver Blood Stasis; C3: Dampness Heat; C4: Spleen Qi Deficiency; C5: Liver
and Kidney Yin Deficiency; C6: Liver Blood Deficiency; C7: Spleen and Kidney Yang Deficiency. aP<0.05, when compared with groups of
StageⅠa, StageⅡa and StageⅢb; bP<0.05, when compared with groups of StageⅠa, StageⅠb, StageⅡa, StageⅡb and StageⅢa.
Table 2 Pattern scores of different staging groups (Kruskal-Wallis)
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(6.5%) were at Stage Ⅰ a, 26 (6.5%) were at Stage Ⅰ
b, 53 (13.3%) were at Stage Ⅱa, 110 (27.6%) were at
Stage Ⅱ b, 155 (38.9% ) were at Stage Ⅲ a, and 28
(7.0%) were at StageⅢb (Table 1).
Statistical analysis of the pattern data
The results of the statistical analysis showed that in the
398 newly diagnosed patients, regardless of the staging,
the scores of Qi Stagnation, Blood Stasis, and Damp-
ness patterns were relatively high, and the scores of Liv-
er Qi Stagnation, Liver Blood Stasis, and Dampness
Heat patterns were also relatively high. When com-
pared among different staging groups, there were signif-
icant differences in scores of Dampness (P = 0.002)
and Liver Qi Stagnation patterns (P = 0.02). The out-
comes of multiple comparison showed that scores of
Dampness pattern in group Stage Ⅲb were statistically
higher than those in any other stage group, and scores
of Liver Qi Stagnation pattern in group StageⅢa were
statistically higher than those in groups Ⅰ a, Ⅱ a andⅢb (Table 2).
The data of the 398 newly diagnosed patients indicat-
ed that Qi Stagnation, Blood Stasis, and Dampness pat-
terns were more frequent than the other basic patterns,
and Liver Qi Stagnation, Liver Blood Stasis, and
Dampness Heat patterns were more prevalent than the
other complex patterns. The results of the statistical
analysis on pattern frequency distribution showed that
Dampness pattern appeared more frequently (P = 0.001)
in group StageⅢb than in other groups (Table 3).
DISCUSSION
It is the trend of modern TCM to treat a certain kind
of disease depending on the pattern as well as the char-
acteristics of the disease itself. Zhao14 commented on
the relationship between the pattern and the disease,
"patterns derive from the disease, so it is impractical to
focus on the patterns regardless of the characteristics of
the disease". By studying the TCM pathogenesis of
PLC, Liu et al 15,16 alleged that the malfunction of the
liver was the underlying pathogenetic mechanism of
PLC, while the localized excessive patterns, like Qi De-
ficiency and Blood Stasis patterns, as well as Phlegm
and Poison Accumulation patterns, usually coexisted
with the general deficient status. According toPan et al 17,18
Deficiency, Poison, and Stasis are the fundamental
pathogenetic causes of PLC, whereas Wu et al 19
thought that Dampness Heat and Poison Accumula-
tion patterns were dominant at the early stages of the
disease. However, with the consumption of the Yin in
the later stages of the disease, Liver and Kidney Yin De-
ficiency patterns tend to increase. Wang et al 20 stated
that the four major symptoms presented at the late
stages of PLC, which were all related to the state of Qi
Stagnation and Blood Stasis, Accumulation of Phlegm
and Dampness because of Spleen Qi Deficiency.
Fang et al 21 concluded that Liver Blood Stasis, Spleen
Pattern
B1
B2
B3
B4
B5
B6
B7
B8
C1
C2
C3
C4
C5
C6
C7
n
126
198
59
155
91
12
42
18
79
78
123
32
11
48
8
Frequncies [rates (%)]
StageⅠa
(n = 26)
4 (15.4)
12 (46.2)
3 (11.5)
8 (30.8)
3 (11.5)
2 (7.7)
2 (7.7)
0 (0.0)
4 (15.4)
5 (19.2)
6 (23.1)
0 (0.0)
0 (0.0)
3 (11.5)
0 (0.0)
6 (23.1)
10 (38.5)
2 (7.7)
12 (46.2)
5 (19.2)
1 (3.8)
1 (3.8)
1 (3.8)
3 (11.5)
4 (15.4)
7 (26.9)
3 (11.5)
0 (0.0)
5 (19.2)
1 (3.8)
StageⅠb
(n = 26)
StageⅡa
(n = 53)
20 (37.7)
22 (41.5)
5 (9.4)
17 (32.1)
15 (28.3)
1 (1.9)
4 (7.5)
2 (3.8)
7 (13.2)
7 (13.2)
11 (20.8)
7 (13.2)
1 (1.9)
8 (15.1)
1 (1.9)
StageⅡb
(n = 110)
36 (32.7)
53 (48.2)
21 (19.1)
42 (38.2)
24 (21.8)
4 (3.6)
18 (16.4)
7 (6.4)
26 (23.6)
26 (23.6)
39 (35.5)
9 (8.2)
6 (5.5)
17 (15.5)
5 (4.5)
StageⅢa
(n = 155)
51 (32.9)
83 (53.5)
25 (16.1)
54 (34.8)
39 (25.2)
3 (1.9)
14 (9.0)
8 (5.2)
34 (21.9)
26 (16.8)
49 (31.6)
10 (6.5)
4 (2.6)
15 (9.7)
1 (0.6)
StageⅢb
(n = 28)
9 (32.1)
18 (64.3)
3 (10.7)
22 (78.6)
5 (17.9)
1 (3.6)
3 (10.7)
0 (0.0)
5 (17.9)
10 (35.7)
11 (39.3)
3 (10.7)
0 (0.0)
0 (0.0)
0 (0.0)
P value
0.399
0.281
0.459
0.001
0.563
0.695
0.279
0.599
0.492
0.145
0.356
0.367
0.368
0.180
0.251
Notes: B1: Qi stagnation; B2: blood stasis; B3: excessive heat; B4: dampness; B5: Qi deficiency; B6: blood deficiency; B7: Yin deficiency;
B8: Yang deficiency; C1: liver Qi stagnation; C2: liver blood stasis; C3: dampness heat; C4: spleen Qi deficiency; C5: liver and kidney Yin
deficiency; C6: liver blood deficiency; C7: spleen and kidney Yang deficiency.
Table 3 Pattern frequencies for the different staging groups (Chi-square test)
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Deficiency, and Qi Stagnation were the fundamental el-
ements in the pathogenesis of PLC, while Ling et al 22
proposed that since Blood Stasis, Spleen Qi Deficiency,
Dampness Heat in Liver and Cholecystitis, and Liver
Qi Stagnation, especially Blood Stasis and Spleen Qi
Deficiency, appeared commonly at every stage of PLC,
they were the most probable contributing factors in the
basic pathogenesis of PLC.
Much has been done in the exploration of the patho-
genesis of PLC, which is derived from the clinical expe-
rience and is certainly helpful to guide clinical practice.
Unfortunately, no consensus has been reached on the
pathogenesis evolution,hence, more direct clinical data
on pathogenesis of PLC are demanded. Before we can
summarize the pathogenesis of PLC, more information
on its patterns is necessary. Therefore, we analyzed and
compared the patterns of the patients at different stag-
es of the disease to better understand the characteristics
of the patterns.
Data of the 398 patients newly diagnosed with PLC in-
dicated that Qi Stagnation, Blood Stasis, and Damp-
ness patterns were more frequent than the other basic
patterns; Liver Qi Stagnation, Liver Blood Stasis, and
Dampness Heat patterns were more frequent than the
other complex patterns. Similar outcomes have been re-
ported in the literature.21 In the present study, we used
quantitative criteria to obtain scores for each pattern,
and established the pattern diagnosis based on the qual-
itative diagnostic criteria. The score of a certain pattern
in a single person represents the amount of signs and
symptoms correlated to the certain pattern the person
has and the degree of the symptoms. Thus, in the 398
PLC patients, the high scores of Qi Stagnation reflect a
high degree of relevant signs and symptoms like chest
stuffiness, abdominal distention, pain of unfixed loca-
tion, and/or depression. Likewise, high scores of Blood
Stagnation reflect the frequency and severity of rele-
vant signs and symptoms like mass in the hypochondri-
ac region, dim and blackish complexion, purple
tongue, and/or petechiae or bruises in the tongue and
sublingual varices. Scores of Dampness reflect frequen-
cy and severity of signs and symptoms like hydrotho-
rax, ascites, lower leg edema and jaundice. Liver Qi
Stagnation reflects depression, frequent sighs, and/or
unfixed or distending pain in the hypochondriac re-
gion. Liver Blood Stasis reflects sublingual varices, pur-
ple tongue, and mass in the hypochondriac region.
Dampness Heat reflects jaundice, dark urine, bitter
mouth, and dry throat.
The scores can be used as scales to evaluate the status
of patterns, and the fluctuation of scores displays the
dynamic changes of the patterns. Scores of a certain
pattern in different groups stand for the pattern status
for the respective group, and comparison of them can
be used to find the differences of pattern statuses
among groups. Scores of different patterns cannot be
compared directly, since the signs and symptoms select-
ed for the scoring criteria are different.
Data of the 398 patients showed that fluctuations of
Dampness patterns were seen throughout the course of
the disease. Further, we found the highest Dampness
pattern scores in the group Stage Ⅲb. Analysis of pat-
tern frequency distribution also showed that the Damp-
ness pattern appeared more frequently in group StageⅢb.
In China, more than 80% of patients with PLC have a
history of chronic hepatitis B, and hepatitis B virus
(HBV) infection. HBV, the pathogen of hepatitis B,
has been considered commonly as a kind of toxin that
can cause Dampness and Heat.23 Our study data
showed that of the 398 patients with PLC, 356
(89.4% ) had a history of hepatitis B. Some patients
presented with symptoms like anorexia, bloating, and
yellowish greasy tongue coating, or even with jaundice,
hydrothorax, or hydroperitoneum in severe cases on
their first visits to the physician. Dampness and Heat
usually affect the middle energizer first, where they dis-
rupt the function of the stomach and spleen. Later on,
the liver will be involved because of the law of spleen
mud illness and because it is prone to liver wood.24
Gradually, a tumor will develop in the liver because of
the toxins accumulated locally. Therefore, Professor
Zhou25 claimed that accumulation of Heat, Dampness,
and toxins locally was the basic pathogenetic mecha-
nism underlying PLC. Results of our study showed
that Dampness patterns in the group Stage Ⅲb were
much more severe, and according to the staging criteria
in terms of modern medicine, patients at Stage Ⅲ b
(Child C) are characterized with severe jaundice (total
bilirubin > 51 μmol/L) and hydroperitoneum; this
matches with the manifestations of the Dampness pat-
tern. Based on the data of the 398 patients newly diag-
nosed with PLC, we concluded that pattern characteris-
tics in patients with PLC at different clinical stages
might manifest in the variations of Dampness pattern
along the progression of the disease and that the major
pathogenic factor of PLC might be Dampness.
The reasons we cannot make affirmative conclusions
are as follows. First, the sample size was not large
enough, since we separated the patients into 7-8 pat-
tern groups and six stage groups. Second, the qualita-
tive and quantitative diagnostic criteria had not been
widely used; thus, their validity needs to be verified re-
peatedly. Third, all the data were adopted at a single
time point, which was the time corresponding to the
patients' hospitalization, and we did not analyze data
obtained from multiple time points or dynamic data.
Only dynamic data can accurately reflect the dynamic
changes of the patterns to reveal the pathogenesis more
precisely.
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